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Abstract Biochemical and histological assays are cur-
rently used for the diagnosis and characterization of kidney
injury. The purpose of this study was to compare tech-
netium-99m-labeled dimercaptosuccinic acid (99mTc-
DMSA) renal scintigraphy, as a non-invasive method, with
common biochemical and histopathological methods in
two animal models of acute kidney injury. Nephrotoxicity
was induced either by gentamicin (100 mg/kg/day for one
week) or unilateral ureteral ligation (UUO). Renal
scintigraphy was performed 1 h after intravenous injection
of 99mTc-DMSA (3 mCi). Furthermore, plasma levels of
blood urea nitrogen (BUN), creatinine, sodium, and
potassium were determined using an autoanalyzer. At the
end of experiments, kidneys were excised for the mea-
surement of activity uptake (mCi/gr) using a dose cali-
brator as well as histopathological examinations with
hematoxylin and eosin (H&E) staining. There was a sig-
nificant decrease in 99mTc-DMSA uptake in both gen-
tamicin (P value = 0.049) and UUO (P value = 0.034)
groups, and it was more significant in the former. The
levels of BUN and creatinine increased in both gentamicin
and UUO groups, while the levels of sodium and potassium
remained unchanged. Furthermore, a strong correlation was
found between DMSA uptake and histopathological find-
ings. Scintigraphy with 99mTc-DMSA is capable of
detection of kidney injury in both gentamicin and UUO
groups. Moreover, a significant correlation was found
between scintigraphy parameters and histopathological
findings. This suggests 99mTc-DMSA as a non-invasive
method for the evaluation of kidney injury induced by
drugs or anatomical disorders.
Keywords Small-animal imaging  Renal scintigraphy 
99mTc-DMSA  Renal function  Gentamicin 
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Introduction
Acute kidney injury (AKI), also known as acute renal
failure is characterized by the rapid loss of kidney function
followed by attenuated urine output and the accumulation
of waste products such as nitrogen metabolites. Treatment
is mainly supportive because no specific treatment has
emerged to decrease acute kidney injury or enhance
recovery. However, patients with AKI are at higher risk for
the development of chronic kidney disease. Therefore,
early diagnosis of AKI will help prevent the development
of chronic conditions with higher rates of morbidity and
mortality [1]. In this regard, several experimental models
are used for understanding the pathophysiology of kidney
injury. Likewise, these methods are implemented for the
development of reliable methods for accurate diagnosis and
potential treatments [2, 3]. These include animal models
derived from drug-induced nephrotoxicity (gentamicin or
cisplatin), nephrotoxicity with ureteral obstruction, and
renal ischemic/reperfusion studies [4, 5].
Kidney injury is associated with accumulated levels of
waste materials as well as alteration of histopathological
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parameters. Therefore, biochemical markers such as blood
urea nitrogen (BUN) and serum creatinine (Cr) along with
histological examinations are used for the evaluation of
kidney function [6, 7]. However, biochemical assays lack
sensitivity to relay acute injury. This is proven by the fact
that any changes in the levels of BUN and Cr require the
loss of at least 75% of functional nephrons [8–10]. Hence,
there should be an extensive damage to the kidneys to
cause an alteration in the levels of BUN and Cr. Also, in
spite of high accuracy, histological examinations have
some disadvantages. These include long run-time, difficult
interpretation, difficulties in following up studies, and the
invasive nature of the methods [11]. Therefore, develop-
ment of non-invasive methods with high accuracy and
sensitivity is of interest for the early diagnosis of renal
dysfunction.
Non-invasive radionuclide imaging has been used for
the assessment of relative renal function [12, 13]. In par-
ticular, renal functional properties can be evaluated using
99mTc-labeled compounds, such as mercaptoacetyl-
triglycine (MAG3), diethylenetriamine pentaacetic acid
(DTPA), and dimercaptosuccinic acid (DMSA)
[11, 14, 15]. In this regard, 99mTc-DMSA is considered as
the radiotracer of choice for the assessment of cortical
damage, estimating regional renal function and detection of
renal parenchymal abnormalities owing to its localization
in proximal tubules [16–20]. In addition, 99mTc-DMSA
uptake is found to correlate with renal blood flow (RBF),
glomerular filtration rate (GFR), and creatinine clearance
[21–23]. However, it is yet to be clarified whether 99mTc-
DMSA scintigraphy can relay acute kidney damage
resulting from anatomical ligation or pharmacological
interventions. In fact, if the results of DMSA scan correlate
well with biochemical and histological findings, this scan
can be used in pre-clinical studies for the screening of
renoprotective agents.
The purpose of this study was to compare 99mTc-
DMSA renal scintigraphy with common biochemical and
histopathological methods in two animal models of acute
kidney injury; (1) gentamicin-induced nephrotoxicity and
(2) complete unilateral ureteral obstruction in rats.
Materials and methods
Animals and experimental groups
Male Sprague–Dawley rats (250–300 g) were used in the
present study. Rats were kept three per cage in a temper-
ature-controlled room (23 ± 1 C) with 12 h light/dark
cycle and had free access to standard rodent diet and water.
The rats were randomly divided into four groups (n = 8):
gentamicin (GM), gentamicin sham (GMS), unilateral
ureteral obstruction (UUO), and unilateral ureteral
obstruction sham (UUOS) groups. All protocols conformed
to the guidelines for the care and handling of animals
prepared by the Ethics Committee in accordance with the
international conventions on animal experimentation [24].
Induction of nephrotoxicity
Nephrotoxicity was induced either by gentamicin or uni-
lateral ureteral ligation. The first group was treated with
gentamicin (100 mg/kg/day, i.p.) in a volume of 1 ml for
7 days [25, 26]. Rats in the sham group received saline of
the same volume as the former group.
Nephrotoxicity was induced via unilateral ureteral
ligation in the second group. The rats were anesthetized
(ketamine (70 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.)
and placed on a thermoregulated surgical table to keep
body temperature at 37 ± 1 C. After disinfection with
Povidone Iodine, a midline incision was made, and the left
ureter was identified. The left ureter was then ligated using
a 4-0 silk string at two points and was cut between the
ligatures in order to prevent retrograde urinary tract
infection. Finally, the incision was closed in 2 layers with
4-0 silk strings [27–29]. The left ureter of rats in the sham
group (UUOS) was exposed and manipulated simply
without ligation. Animals were allowed to recover from
anesthesia prior to returning to individual cages.
Renal scintigraphy and image analysis
Renal scintigraphy was accomplished 7 days after drug or
surgical induction of nephrotoxicity under general anes-
thesia using HiReSPECT (Parto Negar Persia Co., Iran), a
dedicated small-animal SPECT system [30, 31]. The
imaging system is equipped with two gamma camera
detector heads fitted with parallel-hole collimators and
CsI(Na) crystal with 38 9 80 pixels (1 9 1 9 5 mm).
Radionuclide scintigraphy was performed after the prepa-
ration of 99mTc-DMSA according to the manufacturer’s
recommendations. According to the results of our previous
study [32], the recommended image acquisition time for
renal scintigraphy with 99mTc-DMSA in the rat is 1–2 h
post-injection. Hence, 1 h after injection of 3 mCi of
99mTc-DMSA through the tail vein, two opposed planar
images (anterior and posterior) were collected in a 38 9 80
matrix.
Regions of interest (ROIs) were selected around the
kidneys and background areas for both anterior and pos-
terior images. After background correction, the geometric
mean of the anterior and posterior images was used for the
calculation of renal uptake. DMSA uptake was determined
for the left kidney by the calculation of the photon counts
per pixel and the relative uptake which was calculated as
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the left kidney counts to the sum of the left and right
kidney counts.
Biochemical assays
After radionuclide scan, blood samples were taken by heart
puncture and centrifuged at 5000 rpm for 10 min. The
resulting plasma was stored at -20 C for the determina-
tion of BUN, creatinine, sodium (Na?), and potassium
(K?) levels. The serum levels of BUN and creatinine were
determined using an autoanalyzer. Likewise, the serum
concentrations of Na? and K? ions were determined using
the EasyLyte analyzer.
Histopathological examination
At the end of the experiments, the abdomen of the ani-
mals was opened through the midline, renal pedicles were
tied off, and then kidneys were excised. The activity
uptake of the kidneys was measured using a dose cali-
brator (CRC-25R, Capintec, Inc.). The kidneys were then
preserved in 10% formaldehyde buffer for histological
studies.
The preserved kidneys were embedded in paraffin and
5 lm sections were obtained by a microtome. Sec-
tions were then subjected to routine staining with hema-
toxylin and eosin (H&E). Consequently, a pathologist
colleague was asked to examine each section in at least 10
randomly selected non-overlapping fields under a light
microscope in a blind manner. The renal histopathology
was quantified for the degree of Bowman’s space
enlargement, tubular cell necrosis, exfoliated cells in the
lumen, vascular congestion, and intratubular casts [33, 34].
The level of each manifestation was graded according to
the changes involved in comparison with the control group;
scoring 0 for no changes, 1 for changes less than 20%, 2 for
20–40% of change, 3 for 40–60% of change, 4 for 60–80%
of change, and 5 for greater than 80% of change compared
to the control. Finally, the total histopathological score was
calculated as the sum of scores for all regions of the
nephrons.
Statistical analysis
The Statistical Package for Social Sciences (SPSS), version
24, (SPSS Inc., Chicago, IL, USA) was used for statistical
analysis and a P value of less than 0.05 was considered
statistically significant. Continuous variables are presented
as mean ± SD. Mann–Whitney tests were used to compare
the variables between the GM and GMS and also between
the UUO and UUOS groups.
Results
Radionuclide scan
The background activity increased in both GM and UUO
groups compared to their sham groups, particularly in the
GM group (Fig. 1). The ratio of the relative uptake in the left
kidneys of the GM and UUO groups to their amounts in their
sham groups were 1 and 0.5, respectively (Table 1). The
count per pixel decreased from 212 in saline treated to 84 in
gentamicin-treated rats. Likewise, this parameter decreased
from 190 in UUO sham to 78 UUO group. The ratios of the
count per pixel in both of the models to their sham groups
(GM/GMS and UUO/UUOS) were equal to 0.4.
Plasma variables
The BUN level significantly increased from 20 to 72 mg/dl
(P value = 0.001) and 24.5 to 31 mg/dl (P value = 0.02)
in the GM and UUO groups, respectively. The incensement
of the BUN in the GM group was 3 times more than that in
the UUO group. The serum levels of creatinine produced a
similar pattern. Indeed, the creatinine level increased from
0.5 to 2.16 mg/dl (P value\0.001) in the GM group and
from 0.53 to 0.65 mg/dl (P value \0.05) in the UUO
group. On the other hand, there were no significant changes
in the sodium and potassium levels in either of the
nephrotoxicity models compared to their sham groups.
Renal histopathology
The tubular and vascular structures of cortex in right kid-
ney of UUO group were similar to that in the UUOS group
which showed a normal appearance (not shown). In con-
trast, the cortex area of the GM groups and the left kidney
of the UUO groups showed enlargement of Bowman space
as well as epithelial cell damage in proximal tubule (PT)
and thick ascending limb (TAL) of loop of Henle (Fig. 2).
Likewise, the epithelial cells of PT and TAL were
destroyed at the cortex of the GM group and the left kidney
of the UUO group.
Table 2 shows the quantification of the renal
histopathology. Total scores in GM and UUO groups were
4.76 and 1.72, respectively. Injuries in each nephrotoxic
group were higher than their corresponding sham group.
Furthermore, kidney damage in GM group was more sev-
ere than that observed in the left kidney of the UUO group.
Discussion
A variety of pharmacological agents or pathophysiological
conditions can induce kidney damage. In particular, the
clinical application of aminoglycosides is limited because
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of nephrotoxicity and ototoxicity of these agents. In fact,
aminoglycosides contain charged amine functional groups
and are basic in normal body pH. Hence, they exhibit
potent interaction with acidic phospholipids of the plasma
membrane. This suggests acidic phospholipids as the first
binding site for aminoglycosides. Moreover, Megaline, a
multiligand endocytic receptor, also serves as the binding
site for these agents [35]. Consequently, they undergo
endocytosis and concentrate in lysosomes, the Golgi
apparatus, and endoplasmic reticulum. Once a threshold is
reached, they accumulate in the cytosol, alter mitochon-
drial function, and induce apoptosis and necrosis. Fur-
thermore, they hamper the functions of several transporters
compromising electrolyte balance and cell viability. They
also decrease glomerular filtration and renal blood flow
through the increase of intracellular calcium levels, pro-
duction of vasoconstrictors such as thromboxane A2 and
endothelin 1, activation of the renin–angiotensin–aldos-
terone system, and induction of platelet-activating factor
[36]. In addition, aminoglycosides enhance the formation
of free radicals and lipid peroxidation in the presence of
iron salts [37].
Biochemical and histological assays are currently used
for the diagnosis and characterization of kidney injury in
small-animal experiments. However, these methods either
are invasive and time-consuming or lack the desirable
sensitivity for early diagnosis. Therefore, non-invasive
methods are of interest for the evaluation of acute kidney
injury. In this study, we evaluated the quantitative 99mTc-
DMSA renal scintigraphy in comparison with biochemical
and histopathological assays in two animal models of acute
kidney injury; nephrotoxicity was induced by either gen-
tamicin or unilateral ureteral obstruction. In particular,
DMSA uptake in the kidneys was studied in terms of 3
Fig. 1 Renal scintigraphy
images of the animals. The
99mTc-DMSA uptake
decreased in both kidneys of the
rat in GM group and also in the
left kidney of the rat in the UUO
group. Background activity
increased for the rats in both of
the GM and the UUO groups.
GM gentamicin-induced
nephrotoxicity, GMS GM sham
operation, UUO unilateral
ureteral obstruction, UUOS
UUO sham operation
Table 1 Biochemical analysis of plasma levels of BUN, creatinine, sodium, and potassium and results of tissue Tc-99m DMSA uptake in the
GM, GMS, UUO, and UUOS groups
Groups Activity
(mCi)/gr
Tc-99m DMSA Relative uptake
[LC/(RC ? LC)] %
Tc-99m DMSA
uptake (Count/pixel)
BUN (mg/dl) Creatinine
(mg/dl)
Na? (lmol/
ml)
K? (lmol/
ml)
GMS 0.45 ± 0.06 48.8 ± 0.69 212.66 ± 15.04 20.33 ± 5.13 0.51 ± 0.04 143 ± 1.0 3.83 ± 0.32
GM 0.087 ± 0.01 47.06 ± 4.3 84.33 ± 5.5 72 ± 1.41 2.16 ± 0.12 138 ± 2.82 3.1 ± 0.56
P value 0.046 NS 0.049 0.001 \0.001 NS NS
UUOS 0.42 ± 0.04 52.33 ± 1.94 190.33 ± 7.57 24.5 ± 0.70 0.53 ± 0.00 142.5 ± 2.12 4.08 ± 0.02
UUO 0.137 ± 0.06 28.36 ± 5.24 78.25 ± 14.75 31 ± 2.54 0.65 ± 0.06 143.6 ± 2.07 3.98 ± 0.60
P value 0.032 0.034 0.034 0.020 0.044 NS NS
GM gentamicin-induced nephrotoxicity, GMS GM sham operation, UUO unilateral ureteral obstruction, UUOS UUO sham operation, LC left
kidney count, RC right kidney count, BUN blood urea nitrogen, Na sodium, K potassium, NS not significant
Results were expressed as mean ± standard deviation
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parameters. The first parameter was activity per gram
which earned by direct measurement of the concentrated
activity in the kidney using a dose calibrator. Furthermore,
kidney counts per pixel and renal relative uptake were also
determined via quantitative assessment of scintigraphy
images. The activity per gram and count per pixel describe
renal uptake in the unit of kidney mass or pixel of the
kidney in images, respectively.
There was a significant reduction in 99mTc-DMSA
uptake in nephrotoxic groups. This is shown as lower
activity per gram of kidney (dosimetry) as well as lower
count/pixel (scintigraphy) in GM and UUO rats compared
to the corresponding sham groups. In addition, gentamycin
caused more reduction in these values than did ureteral
ligation (Table 1). In this regard, our results are in con-
cordance with Cabuk et al. [15]. They investigated the
potential renoprotective effect of erdosteine against gen-
tamicin-induced renal dysfunction using Tc99m-DMSA
scintigraphy in rats. They showed a significant decrement
in 99mTc-DMSA uptake in GM group compared to the
controls. Also, our results were in agreement with those of
Yamada et al. in this case [21]. They evaluated the 99mTc-
DMSA renal uptake as an absolute renal function by
comparison with endogenous creatinine clearance in cis-
platin-induced nephrotoxicity. They showed that 99mTc-
DMSA uptake in the treated group after 7 days of treat-
ment was significantly lower than that of the control group.
The relative renal uptake describes the ratio of DMSA
uptake in the left kidney to the total uptake in both kidneys.
As indicated in Table 1, relative renal uptake was similar
between gentamicin and its control group. This could be
explained by the fact that gentamicin causes loss of func-
tion in both kidneys. Therefore, relative renal uptake will
be similar in spite of a significant reduction in total kidney
uptake. The results of this study are comparable to those of
Lora-Michiels et al. [38]. They studied the efficiency of
99mTc-DTPA, 99mTc-MAG3, and 99mTc-DMSA in
gentamicin-induced renal injury in mongrel dogs. They
Fig. 2 Renal tissue damages
after nephrotoxicity by
gentamicin and the left kidney
of UUO groups. Representative
light microphotographs of the
juxtamedullary cortex of rats.
Hematoxylin and eosin (H&E)
staining, with indications of
black arrows to Bowman’s
space, white arrows to tubular
damage
Table 2 Scores of tubular cell
injury in cortex area of the left
kidneys in the experimental
groups of rats
Variables GMS GM UUOS UUO
Bowman’s space enlargement 0.00 1.07 ± 0.22 0.00 0.87 ± 0.04
Proximal tubule injury 0.00 1.73 ± 0. 3 0.00 0.67 ± 0.08
Thick ascending limb injury 0.00 1.96 ± 0.03 0.00 0.17 ± 0.08
Distal tubule injury 0.00 0.00 0.00 0.00
Collecting duct injury 0.00 0.00 0.00 0.00
Total histopathological score 0.00 4.76 ± 0.23 0.00 1.72 ± 0.25
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showed that renal function was constant in comparison to
each other and the relative renal function values did not
change for different doses of gentamicin. On the other
hand, our results showed that UUO caused a significant
decrease both in total kidney uptake and relative renal
uptake. This is explained by the fact that ureteral ligation
was performed only in the left kidney while the right ureter
remained intact.
Background activity in nephrotoxic rats was higher than
the corresponding sham groups. Moreover, the difference
between gentamicin and its control was much higher than
that between UUO and its sham-operated group. This could
be due to the compensation of the renal function from the
intact right kidney in UUO group. In other words, the
uptake of DMSA by intact kidney decreases background
activity. Such an effect is absent in gentamicin-treated rats
because of the involvement of both kidneys in this model.
The results of this experiment are comparable to those of
Lora-Michiels et al. [38]. They showed that after the
establishment of injury, the definition of the kidney was
poor due to incensement of the overall background activity.
Nephrotoxicity significantly increased the serum levels
of BUN and creatinine in both models. In addition, such an
increase was much higher in gentamicin model compared
to ureteral ligation. In this regard, Cabuk et al. [15], also,
reported a significant increase of BUN and creatinine in
gentamicin-treated rats. This is while Lora-Michiels et al.
indicated that there was no significant correlation between
BUN or creatinine levels and gentamicin injected dose
[38]. This implies that BUN and creatinine could not
indicate the severity of kidney damage [39]. We induced
nephrotoxicity with a fixed dose of gentamicin. Hence, we
could not investigate whether or not there is a relationship
between the gentamicin dose and renal uptake of DMSA.
In this regard, serum levels of sodium (Na) and potassium
(K) changed neither in gentamycin nor in ureteral ligation
model. The latter could be due to the compensatory effects
of the intact right kidney. However, the exact mechanisms
behind this observation in the former group require further
investigation.
There were some histopathological changes in the left
renal cortex in both models of nephrotoxicity. This
includes Bowman’s space enlargement, tubular cell
necrosis, exfoliated cells in the lumen, vascular congestion,
intratubular casts, and reduction of brush borders. Fur-
thermore, the total histopathological score was much
higher in gentamicin-treated rats compared to UUO group
(4.76 ± 0.23 vs. 1.72 ± 0.25).
The kidney damage in gentamycin-treated rats was more
severe than in UUO group. This is evident both in
scintigraphy and in biochemical or histopathological
assays. Also, there was a good agreement between the
Tc99m-DMSA uptake measured by the dose calibrator and
the Tc99m-DMSA counts measured by the gamma camera.
This shows the ability of 99mTc-DMSA scan to determine
the amount of kidney damage using quantitative image
analysis. Our findings showed that there was a good cor-
relation between the results of histopathological and
scintigraphy assays which was supported by dose calibrator
results. This highlights the fact that quantitative assessment
of DMSA uptake can be implemented not only for the
detection of kidney injury but also for the analysis of the
extent of the injury. The results were in agreement with
previous studies of evaluation hyper-functional uptake of
99mTc-DMSA with contralateral kidney due to unilateral
kidney dysfunction [11, 40].
Conclusion
Quantitative renal 99mTc-DMSA scintigraphy offers a
sensitive and reliable non-invasive method for the detec-
tion of kidney damage in two animal models of nephro-
toxicity. In addition, renal scintigraphy has the capacity to
quantify not only damage to the kidneys but also the extent
of the damage.
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